Trader Note — 8868 total
OFG Bancorp has delivered the Q2 beat the Street was building toward, and the post-earnings reshuffling of positions tells a cleaner story than the anxious setup heading into July 17. The short-side unwind is the most…
ORCL posted its strongest single-day gain in weeks on Tuesday, up 4.7%, yet the week as a whole remains slightly negative — and the options market, which was screaming bullish two weeks ago, has quietly retreated…
Everforth, Inc. walks into tonight's Q2 earnings call — due after the close today — with a fresh analyst upgrade in its pocket, a 7% rally on the week, and a short interest that has been quietly easing. The timing of…
Old National Bancorp heads into the back half of July with an unusual divergence: options traders have turned sharply more cautious while the short sellers who built up positions through June are steadily covering. The…
NVIDIA has reclaimed $207 after last week's slip to $202.81, but the three-week pattern of testing resistance and retreating tells a cleaner story than any single session's move. Tuesday's +2% close to $207.29…
NG enters the back half of July caught between a sharp single-day recovery and a bruising month that has left it well behind the gold mining pack. The stock jumped 8.2% on July 21 to CAD 7.94, a welcome bounce after a…
Northrop Grumman reports Q2 results today with the Street divided on a fresh target revision, options hedging still running near its most defensive level of the year, and the stock down 3.1% on the week at $512.29. The…
Northern Trust enters the back half of July with an unusual tension: the stock is slightly down on the week even as options traders have moved to their most bullish posture in months, and a broad wave of analyst target…
NKE heads into the back half of 2026 with short interest at a multi-month high, options positioning tilting more defensive, and a street divided sharply on whether the bottom is in. The most striking data point right…
Netflix has delivered its Q2 print — and the market's verdict is a further leg down, with the stock now trading at $68.67 and analysts scrambling to reprice a business they still believe in. The earnings reaction was…
MCO reported Q2 results on July 22 and the market's response was swift — the stock dropped nearly 3% to $490.77, pulling back from the bullish pre-earnings positioning that defined the prior two weeks. The month-long…
Micron Technology snapped back 12% on Tuesday to close at $970.82 — recovering nearly all of last week's 13% collapse — yet the stock still trades at a steep discount to where analysts think it belongs, and the options…
MSTR enters its July 30 earnings print with short sellers pulling back and options traders holding their most call-leaning posture in months — a setup that contrasts sharply with the defensive tone that dominated most…
Microsoft enters the final week before its July 29 Q4 results with options defensiveness back at its most extreme reading in months — a sharp reversal from the calm that briefly returned just two days ago. The options…
MET heads into its August 5 earnings report with one of the cleanest analyst upgrade cycles in the insurance sector this summer — ten firms lifting price targets in under three weeks, and the stock still trading below…
Mercantile Bank Corporation delivered a jolt this week, with Q2 results triggering a 3.5% single-day move and pushing the stock up 4.6% on the week to $59.68 — outpacing every close peer by a clear margin, even as…
McKesson has reported earnings today — the July 22 print the prior note flagged — and the market's reaction now sets the tone for what comes next, with the August 5 date already confirmed as the next scheduled…
MasTec enters its July 30 earnings report with short sellers retreating, the Street turning uniformly bullish, and analysts racing each other higher on price targets — a setup that flatters the bull case on paper but…
Marriott International enters its August 3 earnings date with a notable divergence: the Street has spent the past week lifting price targets in unison, while the stock itself is still nursing a 7% loss over the past…
Marsh & McLennan has cleared its Q2 earnings hurdle, but the analyst response to the print has opened a fresh divide on the stock — with one major firm stepping back just as bulls raise their targets. The most notable…
